Cargando…
Ginsenoside Rg3 targets cancer stem cells and tumor angiogenesis to inhibit colorectal cancer progression in vivo
Anti-angiogenic therapy has been successfully applied to treat colorectal cancer (CRC). Ginsenoside Rg3, derived from the Chinese herb ginseng, has anti-vascularization effects and can inhibit tumor growth and metastasis, and can sensitize cancer cells to chemotherapy. Therefore, in the present stud...
Autores principales: | Tang, Yu-Chen, Zhang, Yan, Zhou, Jin, Zhi, Qiaoming, Wu, Meng-Yao, Gong, Fei-Ran, Shen, Meng, Liu, Lu, Tao, Min, Shen, Bairong, Gu, Dong-Mei, Yu, Jie, Xu, Meng-Dan, Gao, Yuan, Li, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5743384/ https://www.ncbi.nlm.nih.gov/pubmed/29115601 http://dx.doi.org/10.3892/ijo.2017.4183 |
Ejemplares similares
-
FH535, a β-catenin pathway inhibitor, represses pancreatic cancer xenograft growth and angiogenesis
por: Liu, Lu, et al.
Publicado: (2016) -
Inhibitory effect of ginsenoside Rg3 combined with gemcitabine on angiogenesis and growth of lung cancer in mice
por: Liu, Tai-Guo, et al.
Publicado: (2009) -
Comparative Pharmacokinetics of Ginsenoside Rg(3) and Ginsenoside Rh(2) after Oral Administration of Ginsenoside Rg(3) in Normal and Walker 256 Tumor-bearing Rats
por: Fan, He, et al.
Publicado: (2016) -
Ginsenoside Rg3 Prolongs Survival of the Orthotopic Hepatocellular Carcinoma Model by Inducing Apoptosis and Inhibiting Angiogenesis
por: Hu, Shen, et al.
Publicado: (2019) -
MiR-23a targets RUNX2 and suppresses ginsenoside Rg1-induced angiogenesis in endothelial cells
por: Wu, Xiao-Dong, et al.
Publicado: (2017)